Enfusion Inc - Ordinary Shares - Class A

NYSE:ENFN  
12.33
+0.08 (+0.65%)
Officer Changes, Other Pre-Announcement

Enfusion Appoints Oleg Movchan Interim Chief Executive Officer

Published: 08/22/2022 15:50 GMT
Enfusion Inc - Ordinary Shares - Class A (ENFN) - Enfusion Appoints Oleg Movchan Interim Chief Executive Officer.
Enfusion Appoints Oleg Movchan Interim Chief Executive Officer.
Enfusion Inc - Reiterates 2022 Q3 and Full Year Revenue Guidance.
Enfusion Inc - Movchan Succeeds Thomas Kim, Who Has Resigned As CEO and As a Director of Co.
Enfusion Inc - Has Retained an Executive Search Firm to Assist With Search Process for Permanent Chief Executive Officer Role.